ArticleFrontiers in oncology2026
Comprehensive management of submandibular salivary duct carcinoma with unilateral axillary lymph node metastasis: a case report.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Salivary duct carcinoma (SDC) is a rare and aggressive malignancy of the salivary glands, most commonly originating in the parotid gland and less frequently in the submandibular gland. Isolated axillary lymph node metastasis is extremely uncommon, and its clinical characteristics and optimal management remain unclear. Case presentation: A 69-year-old man presented with a painless swelling in the left submandibular region. Imaging revealed a submandibular mass with ipsilateral cervical and axillary lymphadenopathy, without distant metastasis. Fine-needle aspiration cytology (FNA cytology) supported the diagnosis of salivary duct carcinoma. The patient underwent left submandibular gland resection with radical neck and axillary lymph node dissection. Histopathology revealed poorly differentiated SDC with metastatic deposits in both cervical and axillary nodes. Genetic testing identified HER2 (ERBB2) gene amplification. Postoperatively, the patient received four cycles of combination chemotherapy with nab-paclitaxel and trastuzumab, followed by one year of trastuzumab maintenance therapy. The treatment was well tolerated, and imaging follow-up at 3, 6, and 12 months showed no recurrence or distant metastasis. Conclusion: Axillary lymph node involvement in submandibular salivary duct carcinoma is extremely rare. To our knowledge, this is the first reported case of isolated unilateral axillary nodal metastasis in the absence of other distant metastases. This case suggests that axillary involvement may represent regional rather than distant spread, and curative surgery remains feasible after comprehensive evaluation. However, this interpretation should be made cautiously because it is based on a single case. Combined chemotherapy and HER2-targeted therapy may achieve favorable short-term outcomes with good tolerability. The accumulation of similar cases is needed to clarify the staging and guide optimal management of such atypical metastases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.